{
    "Trade/Device Name(s)": [
        "SmartestTM Glucowise Blood Glucose Monitoring System, Model 6267-S",
        "SmartestTM Glucowise MULTI Blood Glucose Monitoring System, Model 6267-M"
    ],
    "Submitter Information": "Biotest Medical Corporation",
    "510(k) Number": "K122525",
    "Predicate Device Reference 510(k) Number(s)": [
        "K091815"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "April 03, 2013",
    "Summary Letter Received Date": "April 04, 2013",
    "Submission Date": "May 2, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "SmartestTM Glucowise Blood Glucose Meter",
        "SmartestTM Glucowise MULTI Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose oxidase method",
        "Electrochemical detection"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Test Strips",
        "Control Solutions",
        "Blood Glucose Meter",
        "Lancing Device",
        "Lancets"
    ],
    "Document Summary": "FDA 510(k) summary for Smartest Glucowise Blood Glucose Monitoring Systems Model 6267-S and 6267-M for quantitative glucose measurement in fresh capillary whole blood",
    "Indications for Use Summary": "For quantitative measurement of glucose in fresh capillary whole blood from fingertips or forearm, intended for single-patient home use (Model 6267-S) and multiple-patient professional healthcare use (Model 6267-M) as an aid in monitoring diabetes control, not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}